No new research at the moment
Urothelial
22
Jul
A Randomized Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants with Locally Advanced or Metastati...
All Site
28
Dec
A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physician’s Ch...
Hemato-Oncology
28
Dec
A phase 3, multicenter, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of golcadomide plus R-CH...
Others
12
Nov
Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Unive...
Lung Cancer
23
Sep
Plasma Molecular Profiling in ALK inhibitor resistant non-small cell lung cancer (ARTOG-004)
Non Small Cell Lung Cancer with ALK Inh...
Rare Cancers
23
Sep
Promoting genomic medicine throughout Asia (MASTER KEY ASIA)
University of Malaya Medical Centre (UMMC)
PRINCIPAL INVESTIGATOR
D...
Nasopharyngeal Carcinoma
23
Sep
Asian multicenter prospective study of circulating tumor DNA sequencing (A-TRAIN Nasopharyngeal Carcinoma Project)
Nasopharyngeal Ca...
Cervical Cancer Ovarian Clear Cell Carcinoma N
23
Sep
A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Vers...
Prostate Cancer
23
Sep
Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer (Observational) (PREVALENCE)
Met...